Jamie Singer,Eric Wachter,Amod Sarnaik,Shari Pilon-Thomas,Hao Liu
申请号：
US14974357
公开号：
US20170173079A1
申请日:
2015.12.18
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A cancer immunotherapy method is disclosed in which “induced immune anticancer agents” are isolated after being induced in an animal host by intralesional (IL) administration of a halogenated xanthene tumor-ablative compound into a solid cancerous tumor of that host animal. A sample of the induced immune anticancer agents is removed (collected) from the tumor-bearing host, banked if desired, cultured and preferentially expanded to form an immunologically-effective enriched tumor-specific immune anticancer agent composition. That composition is reintroduced in to the host from which the predecessor induced immune anticancer agents were taken, or into another immunologically suitable host in need.
